|
NCAPG expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.993200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.423000E-01 |
| Normal-vs-Stage2 |
9.205800E-02 |
| Normal-vs-Stage3 |
5.844600E-01 |
| Normal-vs-Stage4 |
8.770200E-01 |
| Stage1-vs-Stage2 |
2.552700E-04 |
| Stage1-vs-Stage3 |
5.615000E-01 |
| Stage1-vs-Stage4 |
7.638200E-01 |
| Stage2-vs-Stage3 |
1.093850E-02 |
| Stage2-vs-Stage4 |
6.055300E-03 |
| Stage3-vs-Stage4 |
4.986800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.472600E-01 |
| Normal-vs-AfricanAmerican |
2.870000E-01 |
| Normal-vs-Asian |
8.913800E-01 |
| Caucasian-vs-AfricanAmerican |
2.480600E-01 |
| Caucasian-vs-Asian |
7.551000E-01 |
| AfricanAmerican-vs-Asian |
1.553000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.954200E-01 |
| Normal-vs-Female |
5.705000E-01 |
| Male-vs-Female |
6.424000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.585600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.964430E-01 |
| Normal-vs-Age(61-80Yrs) |
5.673600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.493600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.192550E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.734830E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.312600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.676200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.059600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.515200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.134200E-01 |
| Classical-VS-Follicular |
1.553750E-04 |
| Classical-VS-Other |
2.130200E-01 |
| Classical-VS-Normal |
8.124600E-01 |
| Tall-VS-Follicular |
7.080200E-03 |
| Tall-VS-Other |
1.951010E-01 |
| Tall-VS-Normal |
9.368200E-01 |
| Follicular-VS-Other |
5.646200E-01 |
| Follicular-VS-Normal |
1.196560E-01 |
| Other-VS-Normal |
3.662000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.506600E-01 |
| Normal-vs-N1 |
5.824000E-01 |
| N0-vs-N1 |
6.332000E-01 |
|
|
